The Toulouse Gérontopôle Research Center: Report of activities, 2007-2011

Journal of Alzheimer's Disease

Volumn 28, Issue 3, 2012, Pages 721-732

  Gillette Guyonnet, Sophie ^a,b,c   Vellas, Bruno ^a,b,c  

^a CHU PURPAN   (France)

^b INSERM   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; NOOTROPIC AGENT;

ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; DRUG MECHANISM; FRANCE; FUNDING; GERIATRIC CARE; GERIATRIC PATIENT; GOVERNMENT; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH ECONOMICS; HEALTH PROMOTION; HUMAN; MEDICAL RESEARCH; MINI MENTAL STATE EXAMINATION; NURSING HOME; PRIORITY JOURNAL;

EID: 84858066079     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-112202     Document Type: Article

References (98)

1. Aisen PS, Gauthier S, Vellas B, Briand R, Saumier D, Laurin J, Garceau D (2007) Alzhemed: A potential treatment for Alzheimer's disease. Curr Alzheimer Res 4, 473-478. (Pubitemid 47416642)
2. Frisoni GB, Henneman WJ, Weiner MW, Scheltens P, Vellas B, Reynish E, Hudecova J, Hampel H, Burger K, Blennow K, Waldemar G, Johannsen P, Wahlund LO, Zito G, Rossini PM,Winblad B, Barkhof F, Alzheimer's Disease Neuroimaging Initiative (2008) The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium. Alzheimers Dement 4, 255-264.
3. Galluzzi S, Talassi E, Belussi M, Scheltens P, van de Pol L, Nobili F, Rodriguez G, Froelich L, Damian M, Martinez-Lage P, Gomez-Isla T, Reynish E, Ousset PJ, Vellas B, Frisoni GB (2008) Multi-center comparison of medial temporal atrophy in patients with Alzheimer's disease-data from the ICTUS study. Dement Geriatr Cogn Disord 26, 314-322.
4. Buerger K, Frisoni G, Uspenskaya O, Ewers M, Zetterberg H, Geroldi C, Binetti G, Johannsen P, Rossini PM, Wahlund LO, Vellas B, Blennow K, Hampel H (2009) Validation of Alzheimer's disease CSF and plasma biological markers: The multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (EADNI). Exp Gerontol 44, 579-585.
5. Liu Y, Paajanen T, Zhang Y, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H, for the AddNeuroMed Consortium (2011) Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups-The AddNeuroMed study. Neurobiol Aging 32(7), 1198-1206.
6. Saumier D, Aisen PS, Gauthier S, Vellas B, Ferris SH, Duong A, Suhy J, Oh J, Lau W, Garceau D, Haine D, Sampalis J (2009) Lessons learned in the use of volumetric MRI in therapeutic trials in Alzheimer's disease: The ALZHEMEDTM (Tramiprosate) Experience. J Nutr Health Aging 13, 370-372.
7. Vellas B, Black R, Thal LJ, Fox NC, Daniels M, McLennan G, Tompkins C, Leibman C, Pomfret M, Grundman M, AN1792 (QS-21)-251 Study Team (2009) Long-term follow-up of patients immunized with AN1792: Reduced functional decline in antibody responders. Curr Alzheimer Res 6, 144- 151.
8. Simmons A, Westman E, Muehlboeck S, Mecocci P, Vellas B, Tsolaki M, lstrok K, oszewska I, Wahlund LO, Soininen H, Lovestone S, Evans A, Spenger C, AddNeuroMed Consortium (2009) MRI measures of Alzheimer's disease and the AddNeuroMed study. Ann N Y Acad Sci 1180, 47-55.
9. Lovestone S, Francis P, Kloszewska I, Mecocci P, Simmons A, Soininen H, Spenger C, Tsolaki M, Vellas B, Wahlund LO, Ward M, AddNeuroMed Consortium (2009) AddNeuroMed-the European collaboration for the discovery of novel biomarkers for Alzheimer's disease. Ann N Y Acad Sci 1180, 36-46.
10. Abellan van Kan G, Andrieu S, Vellas B (2007) GerontoNet A network of Excellence for Clinical Trials with Geriatric Patients. J Nutr Health Aging 11, 251-253.
11. Keime-Guibert F, Abellan G, Nourhashemi F, Tsouderos Y, Merdes A, Vellas B (2007) Rational for a minimum data set for clinical trials with geriatric patients. J Nutr Health Aging 11, 273-277. (Pubitemid 46883582)
12. Vellas B, Andrieu S, Sampaio C, Wilcock G, European Task Force group (2007) Disease-modifying trials in Alzheimer's disease: A European task force consensus. Lancet Neurol 6, 56-62. (Pubitemid 44880273)
13. Abellan van Kan G, Sinclair A, Andrieu S, Olde Rikkert M, Gambassi G, Vellas B (2008) The Geriatric Minimum Data Set for Clinical Trials (GMDS). J Nutr Health Aging 12, 197- 200.
14. Vellas B, Andrieu S, Sampaio C, Coley N, Wilcock G, For the European Task Force Group (2008) Endpoints for trials in Alzheimer's disease: A European task force consensus. Lancet Neurol 7, 436-450.
15. Vellas B, Coley N, Andrieu S (2008) Disease modifying trials in Alzheimer's disease: Perspectives for the future. J Alzheimers Dis 15, 289-301.
16. Coley N, Andrieu S, Delrieu J, Voisin T, Vellas B (2009) Biomarkers in Alzheimer's disease: Not yet surrogate end-points. Ann N Y Acad Sci 1180, 119-124.
17. Lang PO, Heitz D, Meyer N, Drame M, Jovenin N, Ankri J, Somme D, Novella JL, Gauvain JB, Colvez A, Couturier P, Laniece I, Voisin T, de Wazieres B, Gonthier R, Jeandel C, Jolly D, Saint-Jean O, Blanchard F (2007) Early indicators of prolonged hospitalization of the elderly: Pilot study at Strasbourg University Hospital. Presse Med 36(3 Pt 1), 389-398.
18. Lang PO, Meyer N, Heitz D, Drame M, Jovenin N, Ankri J, Somme D, Novella JL, Gauvain JB, Couturier P, Laniece I, Voisin T, de Wazieres B, Gonthier R, Jeandel C, Jolly D, Saint- Jean O, Blanchard F (2007) Loss of independence in Katz's ADLability in connection with an acute hospitalization: Early clinical markers in French older people. Eur J Epidemiol 22, 621-630. (Pubitemid 47402435)
19. Rolland Y, Haren MT, Patrick P, Banks W, Malstrom TK, Miller DK, Morley JE (2007) Adiponectin level in obese and nonobese middle-aged African-American women. Obesity Res Clin Pract 1, 27-37. (Pubitemid 46696585)
20. Rolland Y, Lauwers-Cances V, Cristini C, Grandjean H, Banks W, Morley J, Vellas B (2007) Disability and difficulties for physical function in obese elderly women: Lower limb strength and recreational physical activity. Obesity Res Clin Pract 1, 39-51. (Pubitemid 46710829)
21. Rolland Y, Perry HM, Patrick P, Banks W, Morley M (2007) Loss of appendicular muscle mass and loss of muscle strength in young post-menopausal women. J Gerontol Med Sci 62, 330-335. (Pubitemid 47065732)
22. Abellan van Kan G, Rolland YM, Morley JE, Vellas B (2008) Frailty: Toward a clinical definition. J Am Med Dir Assoc 9, 71-72. (Pubitemid 351189169)
23. Abellan Van Kan A, Rolland Y, Bergman H, Morley JE, Kritchevsky SB, Vellas B (2008) The I.A.N.A Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging 12, 29-37.
24. Drame M, Jovenin N, Novella JL, Lang PO, Somme D, Laniece I, Voisin T, Blanc P, Couturier P, Gauvain JB, Blanchard F, Jolly D (2008) Predicting early mortality among elderly patients hospitalised in medical wards via emergency department: The SAFES cohort study. J Nutr Health Aging 12, 599-604.
25. Drame M, Novella JL, Lang PO, Somme D, Jovenin N, Laniece I, Couturier P, Heitz D, Gauvain JB, Voisin T, De Wazieres B, Gonthier R, Ankri J, Jeandel C, Saint-Jean O, Blanchard F, Jolly D (2008) Derivation and validation of a mortality-risk index from a cohort of frail elderly patients hospitalised in medical wards via emergencies: The SAFES study. Eur J Epidemiol 23, 783-791.
26. Laniece I, Couturier P, Drame M, Gavazzi G, Lehman S, Jolly D, Voisin T, Lang PO, Jovenin N, Gauvain JB, Novella JL, Saint-Jean O, Blanchard F (2008) Incidence and main factors associated with early unplanned hospital readmission among French medical inpatients aged 75 and over admitted through emergency units. Age Ageing 37, 416-422. (Pubitemid 351972201)
27. Rolland Y, Abellan van Kan G, Benetos A, Blain H, Bonnefoy M, Chassagne P, Jeandel C, Laroche M, Nourhashemi F, Orcel P, Piette F, Ribot C, Ritz P, Roux C, Taillandier J, Tremollieres F, Weryha G, Vellas B (2008) Frailty, osteoporosis and hip fracture: Causes, consequences and therapeutic perspectives. J Nutr Health Aging 12, 335-346.
28. Rolland Y, Czerwinski S, Van Kan Abellan G, Morley JE, Cesari M, Onder G, Woo J, Baumgartner R, Pillard F, Boirie Y, Chumlea WM, Vellas B (2008) Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging 12, 433-450.
29. Rolland YM, Hermabessiere S, Abellan G, Nourhashemi F, Bousquet P, Lazorthes Y, Vellas B (2008) Stereotactic radio-surgery for trigeminal neuralgia in a 109-year-old woman. J Am Geriatr Soc 56, 1586-1587.
30. Tremollieres F, Weryha G, Vellas B (2008) Frailty, osteoporosis and hip fracture: Causes, consequences and therapeutic perspectives. J Nutr Health Aging 12, 335-346.
31. Abellan van Kan G, Andre E, Bischoff Ferrari HA, Boirie Y, Onder G, Pahor M, Ritz P, Rolland Y, Sampaio C, Studenski S, Visser M, Vellas B (2009) Carla task force on sarcopenia: Propositions for clinical trials. J Nutr Health Aging 13, 700- 707.
32. Cochen V, Arbus C, Soto ME, Villars H, Tiberge M, Montemayor T, Hein C, Veccherini MF, Onen SH, Ghorayeb I, Verny M, Fitten LJ, Savage J, Dauvilliers Y, Vellas B (2009) Sleep disorders and their impacts on healthy, dependent, and frail older adults. J Nutr Health Aging 13, 322-329.
33. Rizzoli R, Bruyere O, Cannata-Andia JB, Devogelaer JP, Lyritis G, Ringe JD, Vellas B, Reginster JY (2009) Management of osteoporosis in the elderly. Curr Med Res Opin 25, 2373- 2387.
34. Rolland Y, Lauwers-Cances V, Cristini C, van Kan GA, Janssen I, Morley JE, Vellas B (2009) Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: The EPIDOS (EPIDemiologie de l'OSteoporose) Study. Am J Clin Nutr 89, 1895-1900.
35. Andrieu S, Ousset PJ, Coley N, Ouzid M, Mathiex-Fortunet H, Vellas B, GuidAge study GROUP (2008) GuidAge study: A 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. i. rationale, design and baseline data. Curr Alzheimer Res 5, 406-415.
36. Coley N, Andrieu S, Gardette V, Gillette-Guyonnet S, Sanz C, Vellas B, Grand A (2008) Dementia prevention: Methodological explanations for inconsistent results. Epidemiol Rev 30, 35-66.
37. Coley N, Ousset PJ, Andrieu S, Matheix-Fortunet H, Vellas B (2008) Memory complaints to the general practitioner: Data from the GuidAge study. J Nutr Health Aging 12, 66S-72S. (Pubitemid 351156018)
38. Williamson JD, Vellas B, Furberg C, Nahin R, Dekosky ST (2008) Comparison of the design differences between the Ginkgo Evaluation of Memory study and the GuidAge study. J Nutr Health Aging 12, 73S-79S. (Pubitemid 351156019)
39. Andrieu S, Coley N, Aisen P, Carrillo MC, DeKosky S, Durga J, Fillit H, Frisoni GB, Froelich L, Gauthier S, Jones R, Jonsson L, Khachaturian Z, Morris JC, Orgogozo JM, Ousset PJ, Robert P, Salmon E, Sampaio C, Verhey F, Wilcock G, Vellas B (2009) Methodological issues in primary prevention trials for neurodegenerative dementia. J Alzheimers Dis 16, 235-270.
40. Gillette-Guyonnet S, Abellan van Kan G, Andrieu S, Barberger Gateau P, Berr C, Bonnefoy M, Dartigues JF, de Groot L, Ferry M, Galan P, Hercberg S, Jeandel C, Morris MC, Nourhashemi F, Payette H, Poulain JP, Portet F, Roussel AM, Ritz P, Rolland Y, Vellas B (2007) IANA task force on nutrition and cognitive decline with aging. J Nutr Health Aging 11, 132-152.
41. Gillette-Guyonnet S, Andrieu S, Vellas B (2007) The potential influence of silica present in drinking water on Alzheimer's disease and associated disorders. J Nutr Health Aging 11, 119-124. (Pubitemid 46725288)
42. Abellan van Kan G, Gambassi G, de Groot LC, Andrieu S, Cederholm T, Andre E, Caubere JP, Bonjour JP, Ritz P, Salva A, Sinclair A, Vellas B, Dayde J, Deregnaucourt J, Latge C (2008) Nutrition and aging. The Carla Workshop. J Nutr Health Aging 12, 355-364.
43. Gillette-Guyonnet S, Vellas B (2008) Caloric restriction and brain function. Curr Opin Clin Nutr Metab Care 11, 686- 692.
44. Gillette Guyonnet S, Abellan van Kan G, Andrieu S, Aquino JP, Arbus C, Becq JP, Berr C, Bismuth S, Chamontin B, Dantoine T, Dartigues JF, Dubois B, Fraysse B, Hergueta T, Hanaire H, Jeandel C, Lagleyre S, Lala F, Nourhashemi F, Ousset PJ, Portet F, Ritz P, Robert P, Rolland Y, Sanz C, Soto M, Touchon J, Vellas B (2008) Prevention of progression to dementia in the elderly: Rationale and proposal for a health-promoting memory consultation (An IANA Task Force). J Nutr Health Aging 12, 520-529.
45. Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, Fillit H, Foster N, Greenberg B, Grundman M, Sano M, Simpkins J, Schneider LS, Weiner MW, Galasko D, Hyman B, Kuller L, Schenk D, Snyder S, Thomas RG, Tuszynski MH, Vellas B, Wurtman RJ, Snyder PJ, Frank RA, Albert M, Doody R, Ferris S, Kaye J, Koo E, Morrison-Bogorad M, Reisberg B, Salmon DP, Gilman S, Mohs R, Aisen PS, Breitner JC, Cummings JL, Kawas C, Phelps C, Poirier J, Sabbagh M, Touchon J, Khachaturian AS, Bain LJ (2008) A roadmap for the prevention of dementia: The inaugural Leon Thal Symposium. Alzheimers Dement 4, 156-163. (Pubitemid 351682266)
46. Vellas B, Gillette-Guyonnet S, Andrieu S (2008) Memory health clinics-a first step to prevention. Alzheimers Dement 4(1 Suppl 1), S144-S149.
47. George DR, Dangour AD, Smith L, Ruddick J, Vellas B, Whitehouse PJ (2009) The role of nutrients in the prevention and treatment of Alzheimer's disease: Methodology for a systematic review. Eur J Neurol 16(Suppl 1), 8-11.
48. Khachaturian ZS, Cami J, Andrieu S, Avila J, Boada Rovira M, Breteler M, Froelich L, Gauthier S, Gomez-Isla T, Khachaturian AS, Kuller LH, Larson EB, Lopez OL, Martinez-Lage JM, Petersen RC, Schellenberg GD, Sunyer J, Vellas B, Bain LJ (2009) Creating a transatlantic research enterprise for preventing Alzheimer's disease. Alzheimers Dement 5, 361- 366.
49. Carrié I, Abellan Van Kan G, Rolland Y, Gillette-Guyonnet S, Vellas B (2009) PUFA for prevention and treatment of dementia? Curr Pharm Des 15, 4173-4185.
50. Gillette-Guyonnet S, Andrieu S, Dantoine T, Dartigues JF, Touchon J, Vellas B, MAPT Study Group (2009) Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008". The Multidomain Alzheimer Preventive Trial (MAPT): A new approach to the prevention of Alzheimer's disease. Alzheimers Dement 5, 114-121.
51. Abellan van Kan G, Gerard S, Rolland Y, Vellas B (2009) Pneumococcal vaccination in nursing homes. J Am Med Dir Assoc 10, 283.
52. Rolland Y, Abellan van Kan G, Hermabessiere S, Gerard S, Guyonnet Gillette S, Vellas B (2009) Descriptive Study of Nursing Home Residents from the REHPA Network. J Nutr Health Aging 13, 679-683.
53. Voisin T, Laurent B (2007) Best practice use of gerontologic evaluation scales in mobile geriatric units. Soins Gerontol (64) 26-28.
54. Soto ME, Nourhashemi F, Arbus C, Villars H, Balardy L, Andrieu S, Vellas B (2008) Special acute care unit for older adults with Alzheimer's disease. Int J Geriatr Psychiatry 23, 215-219. (Pubitemid 351308503)
55. Aalten P, Verhey FR, Boziki M, Bullock R, Byrne EJ, Camus V, Caputo M, Collins D, De Deyn PP, Elina K, Frisoni G, Girtler N, Holmes C, Hurt C, Marriott A, Mecocci P, Nobili F, Ousset PJ, Reynish E, Salmon E, Tsolaki M, Vellas B, Robert PH (2007) Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: Part I. Dement Geriatr Cogn Disord 24, 457-463. (Pubitemid 350175906)
56. Andrieu S, Rive B, Guilhaume C, Kurz X, Scuvee-Moreau J, Grand A, Dresse A (2007) New assessment of dependency in demented patients: Impact on the quality of life in informal caregivers. Psychiatry Clin Neurosci 61, 234-242. (Pubitemid 46683998)
57. Cortes F, Portet F, Touchon J, Vellas B (2007) Six and 18- month changes in mild to moderate Alzheimer's patients treated with acetylcholinesterase inhibitors: What can we learn for clinical outcomes of therapeutic trials? J Nutr Health Aging 11, 330-337. (Pubitemid 47121934)
58. Gardette V, Coley N, Toulza O, Andrieu S (2007) Attrition in geriatric research: How important is it and how should it be dealt with? J Nutr Health Aging 11, 265-271. (Pubitemid 46883581)
59. Gillette-Guyonnet S, Abellan van Kan G, Alix E, Andrieu S, Belmin J, Berrut G, Bonnefoy M, Brocker P, Constans T, Ferry M, Ghisolfi Marque A, Girard L, Gonthier R, Guerin O, Hervy MP, Jouanny P, Laurain MC, Lechowski L, Nourhashemi F, Raynaud Simon A, Ritz P, Roche J, Rolland Y, Salva T, Vellas B (2007) IANA (International Academy on Nutrition and Aging) Expert Group:Weight Loss and Alzheimer's Disease. J Nutr Health Aging 11, 38-48.
60. Helmer C, Andrieu S, Peres K, Orgogozo JM, Vellas B, Dartigues JF (2007) Predictive value of 6-month decline in ADAScog for survival without severe Alzheimer's disease. Dement Geriatr Cogn Disord 23, 168-174. (Pubitemid 46333784)
61. Petrovic M, Hurt C, Collins D, Burns A, Camus V, Liperoti R, Marriott A, Nobili F, Robert P, Tsolaki M, Vellas B, Verhey F, Byrne EJ (2007) Clustering of behavioural and psychological symptoms in dementia (BPSD): A European Alzheimer's disease consortium (EADC) study. Acta Clin Belg 62, 426- 432.
62. Reynish E, Cortes F, Andrieu S, Cantet C, Olde Rikkert M, Melis R, Froelich L, Frisoni GB, Jonsson L, Visser PJ, Ousset PJ, Vellas B, Study ICTUS, Group (2007) The ICTUS Study: A Prospective longitudinal observational study of 1,380 AD patients in Europe. Study design and baseline characteristics of the cohort. Neuroepidemiology 29, 29-38. (Pubitemid 350191415)
63. Rolland Y, Andrieu S, Cantet C, Morley JE, Thomas D, Nourhashemi F, Vellas B, The REAL.FR Group (2007) Wandering Behavior and Alzheimer Disease. The REAL.FR Prospective Study. Alzheimer Dis Assoc Disord 21, 31-38. (Pubitemid 46398953)
64. Vellas B, Andrieu S, Cantet C, Dartigues JF, Gauthier S (2007) Long-term changes in ADAS-cog: What is clinically relevant for disease modifying trials in Alzheimer? J Nutr Health Aging 11, 338-341. (Pubitemid 47121935)
65. Aalten P, Verhey FR, Boziki M, Brugnolo A, Bullock R, Byrne EJ, Camus V, Caputo M, Collins D, De Deyn PP, Elina K, Frisoni G, Holmes C, Hurt C, Marriott A, Mecocci P, Nobili F, Ousset PJ, Reynish E, Salmon E, Tsolaki M, Vellas B, Robert PH (2008) Consistency of neuropsychiatric syndromes across dementias: Results from the European Alzheimer Disease Consortium. Part II. Dement Geriatr Cogn Disord 25, 1-8. (Pubitemid 350308380)
66. Arbus C, Soto ME, Andrieu S, Nourhashemi F, Camus V, Schmitt L, Vellas B, REAL.FR group (2008) The prevalence of clinically significant depressive symptoms in Alzheimer's disease: Relationship with other psychological and behavioural symptoms. Int J Geriatr Psychiatry 23, 1209- 1211.
67. Benoit M, Andrieu S, Lechowski L, Gillette-Guyonnet S, Robert PH, Vellas B, The real-fr group (2008) Apathy and depression in Alzheimer's disease are associated with functional deficit and psychotropic prescription. Int J Geriatr Psychiatry 23, 409-414. (Pubitemid 351566338)
68. Coley N, Gardette V, Toulza O, Gillette-Guyonnet S, Cantet C, Nourhashemi F, Andrieu S, Grand A, Vellas B (2008) Predictive factors of attrition in a cohort of Alzheimer disease patients. The REAL.FR study. Neuroepidemiology 31, 69-79.
69. Cortes F, Nourhashemi F, Guerin O, Cantet C, Gillette- Guyonnet S, Andrieu S, Ousset PJ, Vellas B, Group REAL-FR (2008) Prognosis of Alzheimer's disease today: A two-year prospective study in 686 patients from the REAL-FR Study. Alzheimers Dement 4, 22-29.
70. Hurt C, Bhattacharyya S, Burns A, Camus V, Liperoti R, Marriott A, Nobili F, Robert P, Tsolaki M, Vellas B, Verhey F, Byrne EJ (2008) Patient and caregiver perspectives of quality of life in dementia. An investigation of the relationship to behavioural and psychological symptoms in dementia. Dement Geriatr Cogn Disord 26, 138-146.
71. Lechowski L, de Stampa M, Denis B, Tortrat D, Chassagne P, Robert P, Teillet L, Vellas B (2008) Patterns of loss of abilities in instrumental activities of daily living in Alzheimer's disease: The REAL cohort study. Dement Geriatr Cogn Disord 25, 46-53. (Pubitemid 350308386)
72. Nourhashemi F, Ousset PJ, Gillette-Guyonnet S, Cantet C, Andrieu S, Vellas B (2008) A 2-year follow-up of 233 very mild (CDR 0.5) Alzheimer's disease patients (REAL.FR cohort). Int J Geriatr Psychiatry 23, 460-465. (Pubitemid 351722104)
73. Nourhashemi F, Vellas B (2008)Weight loss as a predictor of dementia and Alzheimer's disease? Expert Rev Neurother 8, 691-693. (Pubitemid 351656820)
74. Soto ME, Andrieu S, Arbus C, Ceccaldi M, Couratier P, Dantoine T, Dartigues JF, Gillette-Guyonnet S, Nourhashemi F, Ousset PJ, Poncet M, Portet F, Touchon J, Vellas B (2008) Rapid cognitive decline in Alzheimer's disease. Consensus paper. J Nutr Health Aging 12, 703-713.
75. Soto ME, Andrieu S, Cantet C, Reynish E, Ousset PJ, Arbus C, Gillette-Guyonnet S, Nourhashemi F, Vellas B, REAL.FR group (2008) Predictive value of rapid decline in mini mental state examination in clinical practice for prognosis in Alzheimer's disease. Dement Geriatr Cogn Disord 26, 109- 116.
76. Visser PJ, Verhey FR, Boada M, Bullock R, De Deyn PP, Frisoni GB, Frolich L, Hampel H, Jolles J, Jones R, Minthon L, Nobili F, Olde Rikkert M, Ousset PJ, Rigaud AS, Scheltens P, Soininen H, Spiru L, Touchon J, Tsolaki M, Vellas B, Wahlund LO, Wilcock G, Winblad B (2008) Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study. Neuroepidemiology 30, 254-265. (Pubitemid 351871657)
77. Abellan van Kan G, Rolland Y, Nourhashemi F, Coley N, Andrieu S, Vellas B (2009) Cardiovascular disease risk factors and progression of Alzheimer's disease. Dement Geriatr Cogn Disord 27, 240-246.
78. Delrieu J, Voisin T, Andrieu S, Belliard S, Belmin J, Blanchard F, Ceccaldi M, Dartigues JF, Defontaines B, Lehericy S, Mekies C, Moreaud O, Naccache L, Nourhashemi F, Ousset PJ, Pasquier F, Payoux P, Puisieux F, Robert P, Touchon J, Vellas B, Dubois B (2009) Mild Alzheimer's disease: A position paper. J Nutr Health Aging 13, 503-519.
79. Duarte LR, Marquie L, Marquie JC, Terrier P, Ousset PJ (2009) Analyzing feature distinctiveness in the processing of living and non-living concepts in Alzheimer's disease. Brain Cogn 71, 108-117.
80. Germain S, Adam S, Olivier C, Cash H, Ousset PJ, Andrieu S, Vellas B, Meulemans T, Reynish E, Salmon E, The Ictus- Eadc, Network (2009) Does cognitive impairment influence burden in caregivers of patients with Alzheimer's disease? J Alzheimers Dis 17, 105-114.
81. Guerin O, Andrieu S, Schneider SM, Cortes F, Cantet C, Gillette-Guyonnet S, Vellas B (2009) Characteristics of Alzheimer's disease patients with a rapid weight loss during a six-year follow-up. Clin Nutr 28, 141-146.
82. Lechowski L, Benoit M, Chassagne P, Vedel I, Tortrat D, Teillet L, Vellas B (2009) Persistent apathy in Alzheimer's disease as an independent factor of rapid functional decline: The REAL longitudinal cohort study. Int J Geriatr Psychiatry 24, 341-346.
83. Nourhashemi F, Gillette-Guyonnet S, Rolland Y, Cantet C, Hein C, Vellas B (2009) Alzheimer's disease progression in the oldest old compared to younger elderly patient: Data from the REAL.FR study. Int J Geriatr Psychiatry 24, 149-155.
84. Robert P, Onyike CU, Leentjens AF, Dujardin K, Aalten P, Starkstein S, Verhey FR, Yessavage J, Clement JP, Drapier D, Bayle F, Benoit M, Boyer P, Lorca PM, Thibaut F, Gauthier S, Grossberg G, Vellas B, Byrne J (2009) Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur Psychiatry 24, 98-104.
85. Viatonou S, Drame M, Jolly D, Morrone I, Lang PO, Voisin T, Boyer FC, Schwebel G, Somme D, Blanchard F, Novella JL (2009) Predictors of rapid cognitive decline among demented subjects aged 75 or more: ('Sujet Age Fragile- Evaluation et Suivi' Cohort-SAFES). Int J Geriatr Psychiatry 24, 709-715.
86. Voisin T, Vellas B (2009) Diagnosis and treatment of patients with severe Alzheimer's disease. Drugs Aging 26, 135-144.
87. Gillioz AS, Villars H, Voisin T, Cortes F, Gillette-Guyonnet S, Andrieu S, Gardette V, Nourhashemi F, Ousset PJ, Jouanny P, Vellas B and the REAL.fr group (2009) Spared and Impaired Abilities in community dwelling patients entering the sever stage of Alzheimer 's disease. Dement Geriatr Cogn Disord 28, 427-432.
88. Sanz C, Andrieu S, Sinclair A, Hanaire H, Vellas B, For REAL.fr Study Group (2009) Diabetes is associated with a slower rate of cognitive decline in Alzheimer's disease. Neurology 73, 1359-1366.
89. Voisin T, Sourdet S, Cantet C, Andrieu S, Vellas B (2009) Descriptive analysis of hospitalizations of patients with Alzheimer's disease: A two-year prospective study of 686 patients from the REAL.FR study. J Nutr Health Aging 13, 890-892.
90. Gillette-Guyonnet S, Andrieu S, Nourhashemi F, Gardette V, Coley N, Cantet C, Gauthier S, Ousset PJ, Vellas B; REAL.FR study (2011) group. Long-term progression of Alzheimer's disease in patients under antidementia drugs. Alzheimers Dement 7(6), 579-592.
91. Ousset PJ, Nourhashemi F, Reynish E, Vellas B (2008) Nutritional status is associated with disease progression in very mild Alzheimer disease. Alzheimer Dis Assoc Disord 22, 66- 71.
92. Rolland Y, Abellan van Kan G, Nourhashemi F, Andrieu S, Cantet C, Guyonnet-Gillette S, Vellas B (2009) An abnormal "one-leg balance" test predicts cognitive decline during Alzheimer's disease. J Alzheimers Dis 16, 525-531.
93. Rolland Y, Abellan van Kan G, Vellas B (2008) Physical activity and Alzheimer's disease: From prevention to therapeutic perspectives. J Am Med Dir Assoc 9, 390-405.
94. Salva A, Andrieu S, Fernandez E, Schiffrin EJ, Moulin J, Decarli B, Guigoz Y, Vellas B (2009) Health and nutritional promotion program for patients with dementia (NutriAlz Study): Design and baseline data. J Nutr Health Aging 13, 529-537.
95. Salva A, Coll-Planas L, Bruce S, de Groot L, Andrieu S, Abellan G, Vellas B (2009) Nutritional Assessment of Residents in Long-Term Care Facilities (LTCFs): Recommendations of the Task Force on Nutrition and Ageing of the IAGG European Region and the IANA. J Nutr Health Aging 13, 475-483.
96. Rolland Y, Pillard F, Klapouszczak A, Reynish E, Thomas D, Andrieu S, Riviere D, Vellas B (2007) Exercise program for nursing home residents with Alzheimer's disease: A 1-year randomized, controlled trial. J Am Geriatr Soc 55, 158-165. (Pubitemid 46184389)
97. Nourhashemi F, Gillette Guyonnet S, Andrieu S, Rolland Y, Ousset PJ, Vellas B (2008) A randomized trial of the impact of a specific care plan in 1120 Alzheimer's patients (PLASA Study) over a two-year period: Design and baseline data. J Nutr Health Aging 12, 263-271.
98. Nourhashemi F, Andrieu S, Gillette-Guyonnet S, Giraudeau B, Cantet C, Coley N, Vellas B, Group PLASA (2001) Effectiveness of a specific care plan in patients with Alzheimer's disease: Cluster randomised trial (PLASA study). BMJ 340, c2466.